Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
CSFR (mouse)
p Phosphorylation
ac Acetylation
me Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
ub Ubiquitination
sm Sumoylation
ne Neddylation
gl O-GlcNAc
ga O-GalNAc
pa Palmitoylation
ad Adenylylation
sn S-Nitrosylation
ca Caspase cleavage
sc Succinylation

Overview
CSFR an oncogenic tyrosine kinase receptor for CSF-1 (M-CSF). Drives growth and development of monocytes. Binding of CSF-1 induces receptor dimerization, activation and autophosphorylation of cytoplasmic tyrosine residues used as docking sites for SH2-containing signaling proteins. There are at least five major tyrosine autophosphorylation sites. Two point mutations seen in 10-20% of patients with acute myeloid leukemia, chronic myelomonocytic leukemia or myelodysplasia. One mutation appears to be both somatic and germline, and disrupts Cbl binding and receptor turnover. v-fms lacks the Cbl binding site and causes feline leukemia. Mutations may also develop after chemotherapy for lymphoma. A distinct point mutation was found in some cases of hepatocellular carcinoma and related to increased expression, and another mutation was found in 2 of 40 patients with idiopathic myelofibrosis. Expression is elevated in breast tumors and cell lines, and expression in xenografts and transgenic mice has been correlated with xenograft growth and breast cancer development. Inhibitors: Ki-20227 and other Kit/PDGFR inhibitors. Note: This description may include information from UniProtKB.
Protein type: Kinase, protein; Protein kinase, TK; Protein kinase, tyrosine (receptor); EC 2.7.10.1; Membrane protein, integral; TK group; PDGFR family
Cellular Component: cell surface; membrane; plasma membrane; integral to membrane; intracellular; receptor complex
Molecular Function: transferase activity; macrophage colony stimulating factor receptor activity; protein binding; protein homodimerization activity; cytokine binding; protein-tyrosine kinase activity; transferase activity, transferring phosphorus-containing groups; nucleotide binding; kinase activity; transmembrane receptor protein tyrosine kinase activity; protein phosphatase binding; ATP binding; protein kinase activity
Biological Process: regulation of bone resorption; phosphoinositide-mediated signaling; peptidyl-tyrosine phosphorylation; immune system process; positive regulation of osteoclast differentiation; protein amino acid autophosphorylation; cytokine and chemokine mediated signaling pathway; osteoclast differentiation; protein amino acid phosphorylation; positive regulation of tyrosine phosphorylation of Stat3 protein; regulation of cell shape; cell proliferation; positive regulation of cell proliferation; ruffle organization and biogenesis; innate immune response; hemopoiesis; positive regulation of protein amino acid phosphorylation; phosphatidylinositol metabolic process; intercellular junction maintenance; inflammatory response; phosphorylation; transmembrane receptor protein tyrosine kinase signaling pathway; positive regulation of cell migration
Reference #:  P09581 (UniProtKB)
Alt. Names/Synonyms: AI323359; c-fms; CD115; colony stimulating factor 1 receptor; CSF-1-R; CSF-1R; Csf1r; Csfmr; Fim-2; Fms; M-CSFR; Macrophage colony-stimulating factor 1 receptor; OTTMUSP00000015851; Proto-oncogene c-Fms; proto-oncogene fms
Gene Symbols: Csf1r
Molecular weight: 109,179 Da
Basal Isoelectric point: 5.84  Predict pI for various phosphorylation states
CST Pathways:  Tyrosine Kinases & Substrates
Protein-Specific Antibodies or siRNAs from Cell Signaling Technology® Total Proteins
Select Structure to View Below

CSFR

Protein Structure Not Found.


STRING  |  BioGPS  |  Scansite  |  KinBase  |  Pfam  |  RCSB PDB  |  ENZYME  |  Phospho3D  |  Phospho.ELM  |  NetworKIN  |  Source  |  UCSD-Nature  |  UniProtKB  |  Entrez-Gene  |  Ensembl Gene


Sites Implicated In
apoptosis, altered: Y807‑p
apoptosis, inhibited: Y559‑p, Y807‑p
cell cycle regulation: Y559‑p, Y697‑p, Y807‑p
cell differentiation, altered: Y544‑p, Y559‑p, Y697‑p, Y721‑p, Y807‑p, Y974‑p
cell growth, altered: Y544‑p, Y559‑p, Y697‑p, Y721‑p, Y807‑p, Y921‑p
cell motility, altered: Y559‑p, Y697‑p, Y721‑p
cytoskeletal reorganization: Y559‑p, Y697‑p, Y706‑p, Y721‑p, Y921‑p, Y974‑p
transcription, altered: Y559‑p, Y807‑p
transcription, induced: Y559‑p, Y807‑p
activity, induced: Y559‑p, Y697‑p, Y706‑p
enzymatic activity, induced: Y544‑p, Y559‑p, Y697‑p, Y706‑p, Y721‑p, Y807‑p
molecular association, regulation: Y559‑p, Y697‑p, Y721‑p, Y807‑p, Y921‑p, Y974‑p
phosphorylation: Y559‑p
protein degradation: Y559‑p

Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       mouse

 
0 1 T179 SNTYVCKTMVNGRES
0 1 Y360-p TQRAIYRytFKLFLN
0 2 T361-p QRAIYRytFKLFLNR
0 1 K363 AIYRytFKLFLNRVK
0 1 Y495-p SVGNSSQyFRAVSLG
4 0 Y544-p KYKQKPKyQVRWKII
0 1 R553 VRWKIIERYEGNSyT
0 7 Y554 RWKIIERYEGNSyTF
0 1 S558 IERYEGNSyTFIDPT
10 7 Y559-p ERYEGNSyTFIDPTQ
0 1 T560 RYEGNSyTFIDPTQL
0 1 T565 SyTFIDPTQLPYNEk
0 5 Y569 IDPTQLPYNEkWEFP
0 2 K572-ub TQLPYNEkWEFPRNN
0 3 K584-ub RNNLQFGkTLGAGAF
0 3 K604-ub ATAFGLGkEDAVLkV
0 1 K610-ub GkEDAVLkVAVKMLK
0 1 S684 AEAMLGPSLSPGQDs
0 2 S686 AMLGPSLSPGQDsEG
0 1 S691-p SLSPGQDsEGDssyk
0 2 S695-p GQDsEGDssykNIHL
0 1 S696-p QDsEGDssykNIHLE
14 36 Y697-p DsEGDssykNIHLEK
0 1 K698-ub sEGDssykNIHLEKK
12 0 Y706-p NIHLEKKyVRRDsGF
0 5 S711-p KKyVRRDsGFsSQGV
0 2 S714-p VRRDsGFsSQGVDTy
14 1 Y721-p sSQGVDTyVEMRPVS
0 1 K737-ub SSSDSFFkQDLDKEA
0 1 K791-ub LTSGHVAkIGDFGLA
21 14 Y807-p DIMNDSNyVVkGNAR
0 3 K810-ub NDSNyVVkGNARLPV
0 2 K868-ub NKFYKLVkDGYQMAQ
0 7 Y871 YKLVkDGYQMAQPVF
3 2 Y921-p LERRDQDyANLPSSG
2 0 Y974-p PLLQPNNyQFC____
3083 : Phospho-M-CSF Receptor (Tyr546) Antibody
3399 : Phospho-M-CSF Receptor (Tyr699) Antibody
3080 : Phospho-M-CSF Receptor (Tyr708) Antibody
3151 : Phospho-M-CSF Receptor (Tyr723) Antibody
3155 : Phospho-M-CSF Receptor (Tyr723) (49C10) Rabbit mAb
3154 : Phospho-M-CSF Receptor (Tyr809) Antibody
3406 : Phospho-M-CSF Receptor (Tyr923) Antibody
  human

 
S178-p QSQDYQCsALMGGRK
H362 TTKDTYRHtFtLSLP
T363-p TKDTYRHtFtLSLPR
T365-p DTYRHtFtLSLPRLK
A497 SVGSGSWAFIPISAG
Y546-p KYKQKPKyQVRWKII
S555-p VRWKIIEsyEGNsyt
Y556-p RWKIIEsyEGNsytF
S560-p IEsyEGNsytFIDPt
Y561-p EsyEGNsytFIDPtQ
T562-p syEGNsytFIDPtQL
T567-p sytFIDPtQLPyNEK
Y571-p IDPtQLPyNEKWEFP
K574 tQLPyNEKWEFPRNN
K586-ub RNNLQFGkTLGAGAF
K606 ATAFGLGKEDAVLKV
K612 GKEDAVLKVAVKMLK
S686-p AEAMLGPsLsPGQDP
S688-p AMLGPsLsPGQDPEG
P693 sLsPGQDPEGGVDyK
V697 GQDPEGGVDyKNIHL
D698 QDPEGGVDyKNIHLE
Y699-p DPEGGVDyKNIHLEK
K700 PEGGVDyKNIHLEKK
Y708-p NIHLEKKyVRRDsGF
S713-p KKyVRRDsGFsSQGV
S716-p VRRDsGFsSQGVDTy
Y723-p sSQGVDTyVEMRPVS
E739 SSNDSFSEQDLDKED
K793 LTNGHVAKIGDFGLA
Y809-p DIMNDSNyIVkGNAR
K812-ub NDSNyIVkGNARLPV
K870-ub SKFYKLVkDGyQMAQ
Y873-p YKLVkDGyQMAQPAF
Y923-p EDRRERDyTNLPSSS
Y969 PLLQPNNYQFC____
3083 : Phospho-M-CSF Receptor (Tyr546) Antibody
3399 : Phospho-M-CSF Receptor (Tyr699) Antibody
12251 : Phospho-M-CSF Receptor (Tyr699) (D10B11) Rabbit mAb
3080 : Phospho-M-CSF Receptor (Tyr708) Antibody
3151 : Phospho-M-CSF Receptor (Tyr723) Antibody
3155 : Phospho-M-CSF Receptor (Tyr723) (49C10) Rabbit mAb
3154 : Phospho-M-CSF Receptor (Tyr809) Antibody
3406 : Phospho-M-CSF Receptor (Tyr923) Antibody
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.